Jong S M, Wang L H
Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029-6574.
J Virol. 1991 Jan;65(1):180-9. doi: 10.1128/JVI.65.1.180-189.1991.
The transforming protein of the avian sarcoma virus UR2 is a 68-kDa transmembrane tyrosine protein kinase. We examined the relationship between membrane localization and transforming activity of P68 by changing Val-168-Val-169 in its hydrophobic domain into Asp-168-Glu-169. The resulting transmembrane (TM) mutant (P68TM) lost transforming activity toward chicken embryo fibroblasts (CEF). We found that the mutant protein was expressed and rapidly degraded into a smaller form which was still membrane associated and kinase active. The instability of the TM mutant protein is a phenomenon only manifested in CEF, because the same mutant protein was expressed with efficiency and stability similar to those of the wild-type protein in a transient expression system in COS cells. However, there are several differences between the wild-type and the TM mutant proteins in COS cells. The wild-type protein is more heavily phosphorylated and associated with membrane fractions in a cotranslational manner. It is enzymatically active when recovered from membrane fractions. The TM mutant protein is less phosphorylated, more labile toward protease degradation, and delayed in membrane association, with a lag period of 30 min or longer, and has little kinase activity when recovered from membrane fractions. Most of the kinase-active TM mutant protein was found in the cytosol fractions. Despite the delay, most of the TM protein in COS cells was found to be membrane associated, and its orientation on the cell surface was similar to that of the wild-type protein. It is probable that loss of the CEF-transforming activity of the TM mutant protein is due to its susceptibility to protease degradation resulting from improper membrane association of the newly synthesized product. The differences in the kinetics of membrane association and the distribution of kinase activity in COS cells might not be directly applicable in explaining the inability of the TM mutant to transform CEF but are intriguing as regards protein biosynthesis and translocation. The difference between CEF and COS cells implies that different factors or pathways are involved in the biosynthesis and processing of the TM mutant protein in these two cellular environments. Changes of P68TM in the kinetics of membrane association indicate that the transmembrane domain of ros, besides functioning as a membrane anchor, also plays a role in directing initial membrane association.
禽肉瘤病毒UR2的转化蛋白是一种68 kDa的跨膜酪氨酸蛋白激酶。我们通过将其疏水区的Val-168-Val-169替换为Asp-168-Glu-169,研究了P68的膜定位与转化活性之间的关系。产生的跨膜(TM)突变体(P68TM)对鸡胚成纤维细胞(CEF)失去了转化活性。我们发现突变蛋白能够表达,但会迅速降解为一种较小的形式,这种较小形式仍然与膜相关且具有激酶活性。TM突变蛋白的不稳定性是一种仅在CEF中出现的现象,因为在COS细胞的瞬时表达系统中,相同的突变蛋白能够以与野生型蛋白相似的效率和稳定性进行表达。然而,在COS细胞中,野生型蛋白和TM突变蛋白之间存在一些差异。野生型蛋白磷酸化程度更高,并且以共翻译的方式与膜组分相关联。从膜组分中回收时,它具有酶活性。TM突变蛋白磷酸化程度较低,对蛋白酶降解更不稳定,并且在膜结合方面存在延迟,延迟期为30分钟或更长时间,从膜组分中回收时几乎没有激酶活性。大多数具有激酶活性的TM突变蛋白存在于细胞质组分中。尽管存在延迟,但在COS细胞中发现大多数TM蛋白与膜相关,并且其在细胞表面的方向与野生型蛋白相似。TM突变蛋白丧失CEF转化活性可能是由于新合成产物的膜结合不当导致其易受蛋白酶降解。在COS细胞中膜结合动力学和激酶活性分布的差异可能无法直接用于解释TM突变体无法转化CEF的原因,但在蛋白质生物合成和转运方面很有趣。CEF和COS细胞之间的差异表明,在这两种细胞环境中,TM突变蛋白的生物合成和加工涉及不同的因素或途径。P68TM在膜结合动力学方面的变化表明,ros的跨膜结构域除了作为膜锚定发挥作用外,还在指导初始膜结合方面发挥作用。